US › Healthcare

Medicus Pharma Ltd. Common Stock (MDCX)

US · Healthcare · Drug Manufacturers - General

$0.30+1.00%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-6.6M

Profit YoY

-29.2%

EPS

$-0.30

EPS estimate

$-0.22

EPS came in at -0.30 against a street estimate of -0.22 — a miss of 36.4%.

Key statistics

Market cap

$17.1M

Forward P/E

0.0

P/B

11.90

Book value

$0.03

EPS (TTM)

$-2.63

52-week high

$3.05

52-week low

$0.25

50-day MA

$0.37

200-day MA

$1.04

Beta

-0.48

Analyst view

with an average price target of $4.50.

Shareholding

Insiders

12.48%

Institutions

3.67%

Largest institutional holders

Fund	Stake
Interchange Capital Partners, LLC	2.93%
Private Advisor Group, LLC	0.42%
Virtu Financial LLC	0.13%
Bryn Mawr Trust Company	0.09%
May Hill Capital, LLC	0.09%
Commonwealth Equity Services, LLC	0.09%
UBS Group AG	0.07%
BlackRock Inc	0.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Medicus Pharma Ltd. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.